These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3301601)

  • 21. [Therapy of nocturnal bronchial asthma: comparison of various doses of retard theophylline].
    Dorow P; Steinijans VW
    Prax Klin Pneumol; 1987 Oct; 41(10):442-4. PubMed ID: 3325964
    [No Abstract]   [Full Text] [Related]  

  • 22. [Theophylline therapy: patient compliance and dosage. A clinical study].
    Kerschl J; Nolte D
    Fortschr Med; 1988 Sep; 106(27):554-7. PubMed ID: 3053376
    [No Abstract]   [Full Text] [Related]  

  • 23. [Improvement of ventilation in patients with restrictive and irreversible obstructive ventilation disorders by a single dose of theophylline].
    Radenbach D; Gatzemeier U; Schulz HU
    Prax Klin Pneumol; 1985 May; 39(5):159-61. PubMed ID: 4022928
    [No Abstract]   [Full Text] [Related]  

  • 24. Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature.
    Hamdy RC; Micklewright M; Beecham VF; Moore SW
    J Tenn Med Assoc; 1995 Dec; 88(12):463-4. PubMed ID: 8531477
    [No Abstract]   [Full Text] [Related]  

  • 25. Theophylline once-a-day dosage.
    Lieberman J
    Chest; 1986 Oct; 90(4):623-5. PubMed ID: 3757579
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion].
    Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP
    Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Increase of arterial oxygen pressure in therapy with theophylline in patients with obstructive ventilation disorder and partial respiratory insufficiency].
    Schmidt EW; Ulmer WT
    Prax Klin Pneumol; 1988 Jul; 42(7):600-2. PubMed ID: 3054862
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
    Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
    Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
    Lal S; Bhalla KK; Davey AJ
    Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pluridirectional treatment of chronic, obstructive bronchopneumopathy with rectal administration of a new drug combination].
    Nappi L; Taglialatela G; Verde F
    Clin Ter; 1972 Dec; 63(6):577-86. PubMed ID: 4570863
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 39. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.